康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688185 康希诺

已收盘 04-11 15:00:01

{"stockData":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":55.28,"timestamp":1744354801000,"preClose":54.78,"halted":0,"volume":1242048,"delay":0,"changeRate":0.0091,"floatShares":114999999,"shares":247000000,"eps":2.9298,"marketStatus":"已收盘","change":0.5,"latestTime":"04-11 15:00:01","open":54.08,"high":55.85,"low":54.08,"amount":68631700,"amplitude":0.0323,"askPrice":55.28,"askSize":5,"bidPrice":55.27,"bidSize":8,"shortable":0,"etf":0,"ttmEps":2.9298,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1744594200000},"marketStatusCode":5,"adr":0,"adjPreClose":54.78,"symbolType":"stock_kcb","openAndCloseTimeList":[[1744335000000,1744342200000],[1744347600000,1744354800000]],"highLimit":60.26,"lowLimit":49.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":247449899,"isCdr":false,"pbRate":2.79,"roa":"--","peRate":18.868182,"roe":"--","epsLYR":-1.53,"committee":0.273885,"marketValue":13679000000,"turnoverRate":0.0108,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-04-14。","afterMarket":{"amount":0,"volume":0,"close":55.28,"buyVolume":1380,"sellVolume":0,"time":1744356838029,"indexStatus":"已收盘 04-11 15:30:00","preClose":54.78},"hkstockBrief":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":29.7,"timestamp":1744358899036,"preClose":28.4,"halted":0,"volume":1514649,"delay":0,"premium":"-49.56"},"floatMarketCap":6345000000},"requestUrl":"/m/hq/s/688185","defaultTab":"news","newsList":[{"id":"2518790640","title":"康希诺03月11日主力净流出409万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2518790640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518790640?lang=zh_cn&edition=full","pubTime":"2025-03-11 15:21","pubTimestamp":1741677716,"startTime":"0","endTime":"0","summary":"03月11日, 康希诺股价跌1.09%，报收61.82元，成交金额7770万元，换手率1.10%，振幅1.66%，量比1.03。康希诺今日主力资金净流出409万元，上一交易日主力净流入175万元。该股近5个交易日下跌2.80%，主力资金累计净流出819万元；近20日主力资金累计净流出3465万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311163956a1d49451&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311163956a1d49451&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2518137012","title":"全国政协委员、康希诺生物首席科学官朱涛：我国正处于疫苗研发的“黄金十年”，免疫规划体系将持续完善","url":"https://stock-news.laohu8.com/highlight/detail?id=2518137012","media":"21经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518137012?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:37","pubTimestamp":1741595820,"startTime":"0","endTime":"0","summary":"然而，随着疫苗种类的增多，传染病种类的变化，扩大免疫规划疫苗种类的呼声越来越高。全国政协委员、康希诺生物首席科学官朱涛在接受南方财经全媒体集团全国两会报道组记者采访时表示，从2020年往后十年，可以说是疫苗供应端、研发端的“黄金十年”，一系列的品种都有望在这10年上市。朱涛表示，具体纳入哪些疫苗，要计算纳入疫苗以后对公共卫生有多大受益。2021年，康希诺生物的4价流脑结合疫苗获批，又填补了一项空白。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031016461598a25800&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031016461598a25800&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","BK1515","BK1574","688185","06185"],"gpt_icon":0},{"id":"2518471790","title":"康希诺朱涛：mRNA肿瘤疫苗是布局方向，国家免疫规划扩容需考虑供应稳定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2518471790","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518471790?lang=zh_cn&edition=full","pubTime":"2025-03-09 08:35","pubTimestamp":1741480551,"startTime":"0","endTime":"0","summary":"mRNA技术平台可应用于多类生物制品的开发，包括肿瘤领域及免疫治疗也可以是拓展方向。近两年，呼吁将某些二类疫苗纳入国家免疫规划的声音不断出现。对此，朱涛认为，具体纳入哪些疫苗或者先纳入哪一个，背后需要详细的计算，纳入后到底能带来多大的公共卫生收益，这不仅要考虑价格，还要考虑供应的稳定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309085913a2675d92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309085913a2675d92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","06185","688185","BK1161","BK1574"],"gpt_icon":0},{"id":"2517113108","title":"康希诺03月07日主力净流出572万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517113108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517113108?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:22","pubTimestamp":1741332151,"startTime":"0","endTime":"0","summary":"03月07日, 康希诺股价跌2.19%，报收63.09元，成交金额8051万元，换手率1.10%，振幅3.16%，量比0.87。康希诺今日主力资金净流出572万元，上一交易日主力净流入242万元。该股近5个交易日下跌1.24%，主力资金累计净流出1476万元；近20日主力资金累计净流出3219万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307164402abecbd69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307164402abecbd69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2517133791","title":"康希诺03月06日主力净流入242万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517133791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517133791?lang=zh_cn&edition=full","pubTime":"2025-03-06 15:21","pubTimestamp":1741245709,"startTime":"0","endTime":"0","summary":"03月06日, 康希诺股价涨2.95%，报收64.50元，成交金额8802万元，换手率1.19%，振幅3.48%，量比0.82。康希诺今日主力资金净流入242万元，上一交易日主力净流出257万元。该股近5个交易日下跌4.84%，主力资金累计净流出3119万元；近20日主力资金累计净流出3850万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306163445a2622071&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306163445a2622071&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2517777972","title":"康希诺生物盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517777972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517777972?lang=zh_cn&edition=full","pubTime":"2025-03-06 09:40","pubTimestamp":1741225255,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时40分，康希诺生物股票出现波动，股价大幅拉升5.00%。截至发稿，该股报37.800港元/股，成交量52.14万股，换手率0.39%，振幅3.33%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中，整体涨幅为0.93%。康希诺生物公司简介：许可项目:第三类医疗器械经营;药品生产;药品进出口;药品零售;药品批发;货物进出口;技术进出口。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094055abea71f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094055abea71f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","BK0239","688185"],"gpt_icon":0},{"id":"2516791656","title":"全国政协委员、康希诺生物首席科学官朱涛：希望通过政策优化医药创新生态 支持医药创新成果转化","url":"https://stock-news.laohu8.com/highlight/detail?id=2516791656","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516791656?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:06","pubTimestamp":1741021575,"startTime":"0","endTime":"0","summary":"医药创新成果的转化效率，直接关系着人民的生命健康。目前，医药创新成果转化过程较为复杂，涉及科研机构、企业、监管部门等多个主体，现有的部分政策和机制一定程度上制约了成果转化的效率。为此，希望通过政策优化医药创新生态、支持医药创新成果转化，可以在审批流程上进行改进，提高疫苗等新药上市转化效率。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304010616989a3325&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304010616989a3325&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239","159938"],"gpt_icon":0},{"id":"2516868398","title":"康希诺：mRNA技术平台可应用于多类生物制品的开发，包括肿瘤领域及免疫治疗也可以是拓展方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2516868398","media":"互动易","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516868398?lang=zh_cn&edition=full","pubTime":"2025-03-03 17:09","pubTimestamp":1740992941,"startTime":"0","endTime":"0","summary":"有投资者向康希诺提问， 贵公司上海康希诺的定位是什么？疫苗+药品是公司唯一壮大的途径，上海康希诺未来是否向创新肿瘤药和创新免疫药方面发展？谢谢。公司回答表示，尊敬的投资人您好，康希诺上海子公司主要为mRNA技术等前沿技术的探索与技术积累转化而设立。mRNA技术平台可应用于多类生物制品的开发，包括肿瘤领域及免疫治疗也可以是拓展方向。现阶段公司将在做好主营业务的基础上进行延展探索。未来如有阶段性进展，将及时分享。谢谢！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303171942a25cddb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303171942a25cddb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","06185","BK1191","BK1574","688185"],"gpt_icon":0},{"id":"2516750451","title":"康希诺03月03日遭主力抛售715万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516750451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516750451?lang=zh_cn&edition=full","pubTime":"2025-03-03 15:20","pubTimestamp":1740986425,"startTime":"0","endTime":"0","summary":"03月03日, 康希诺股价跌0.41%，报收63.62元，成交金额9307万元，换手率1.26%，振幅3.44%，量比0.57。康希诺今日主力资金净流出715万元，连续4日净流出，上一交易日主力净流出2215万元。|03月03日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|N毓恬冠佳|22.87%|#|长荣股份|5.96%|#|贝瑞基因|5.64%|#|永鼎股份|4.50%|#|皇庭国际|4.37%|#|塞力医疗|4.28%|#|丰立智能|4.20%|#|深康佳Ａ|4.11%|#|云鼎科技|3.92%|#|金奥博|3.87%|康希诺所在的生物制品行业，今日主力净流出4458万元，行业排名65/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303160608abe5ae59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303160608abe5ae59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2514031112","title":"康希诺02月28日遭主力抛售2215万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514031112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514031112?lang=zh_cn&edition=full","pubTime":"2025-02-28 15:19","pubTimestamp":1740727199,"startTime":"0","endTime":"0","summary":"02月28日, 康希诺股价跌5.75%，报收63.88元，成交金额1.37亿元，换手率1.83%，振幅6.58%，量比0.86。康希诺今日主力资金净流出2215万元，连续3日净流出，上一交易日主力净流出865万元。该股近5个交易日下跌0.51%，主力资金累计净流出2903万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出3008万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228160018a2578699&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228160018a2578699&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2514923943","title":"康希诺大跌5% 业绩快报净亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2514923943","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514923943?lang=zh_cn&edition=full","pubTime":"2025-02-28 14:02","pubTimestamp":1740722525,"startTime":"0","endTime":"0","summary":"02月28日，康希诺股价大幅下跌，截至14点02分，康希诺下跌5.18%，报64.27元/股，成交1.10亿元，换手率1.45%。消息解读康希诺披露2024年度业绩快报，公司实现营业收入8.46亿元，同比增加137.01%；实现归属于母公司所有者的净亏损3.79亿元，同比亏损减少；实现归属于母公司所有者的扣除非经常性损益的净亏损4.41亿元。主营业务及业绩康希诺公司主营业务为研发、生产和商业化符合中国及国际标准的创新型疫苗企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281402219895e2b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281402219895e2b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2514690973","title":"康希诺生物盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514690973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514690973?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:53","pubTimestamp":1740707587,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘09时53分，康希诺生物股票出现波动，股价快速跳水5.08%。截至发稿，该股报39.200港元/股，成交量50.56万股，换手率0.38%，振幅5.33%。康希诺生物股票所在的生物技术行业中，整体涨幅为2.05%。公告显示，康希诺2024年实现营收8.46亿元，同比增加137.01%，净利润为亏损3.79亿元，同比缩窄了74.45%，扣非后净利润亏损为4.41亿元，同比减少了72.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095307abe00b71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095307abe00b71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","06185","BK1161","BK1191","688185","BK1574"],"gpt_icon":0},{"id":"2514480470","title":"康希诺去年亏损收窄超7成","url":"https://stock-news.laohu8.com/highlight/detail?id=2514480470","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514480470?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:56","pubTimestamp":1740660960,"startTime":"0","endTime":"0","summary":"来源：@究竟视频微博    2月27日，康希诺发布的2024年业绩快报显示，亏损在大幅收窄。2024年，康希诺实现营业收入8.46亿元，同比增加137.01%；归属于母公司所有者的净利润亏损3.79亿元，同比亏损减少74.45%。2023年，康希诺归属于母公司所有者的净利润亏损达到14.83亿元，创下公司2020年登陆科创板上市以来年度亏损之最，主要受新冠疫苗业务拖累。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2025-02-27/doc-inemxvsi0674073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2514767758","title":"康希诺(688185.SH)2024年度净亏损3.79亿元，同比亏损减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2514767758","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514767758?lang=zh_cn&edition=full","pubTime":"2025-02-27 17:56","pubTimestamp":1740650203,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺(688185.SH)披露2024年度业绩快报，公司实现营业收入8.46亿元，同比增加137.01%;实现归属于母公司所有者的净亏损3.79亿元，同比亏损减少;实现归属于母公司所有者的扣除非经常性损益的净亏损4.41亿元。基本每股亏损1.53元。报告期内，营业总收入同比增加137.01%，变动主要系：曼海欣®作为中国市场上唯一的四价流脑结合疫苗，公司通过对其市场的精准布局推动持续放量，产品渗透率不断提升，实现销量快速增长;同时，公司经营受全球公共卫生事件的影响已经基本消除。因此，公司营业收入较去年同期大幅增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2514820540","title":"康希诺2024年度业绩快报：营收8.46亿元 同比增137.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514820540","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514820540?lang=zh_cn&edition=full","pubTime":"2025-02-27 16:47","pubTimestamp":1740646020,"startTime":"0","endTime":"0","summary":"2月27日，康希诺发布公告，2024年度业绩快报显示，公司实现营业总收入8.46亿元，同比增加137.01%。在亏损方面，归母净利润约亏损3.79亿元；扣除非经常性损益的归母净利润约亏损4.41亿元。基本每股收益为-1.53元，较上年同期的-6.01元有所改善。公告中提到，公司总资产为79.58亿元，同比减少14.6%；归属于母公司的所有者权益为49.1亿元，同比减少6.91%。2024年前三季度，康希诺实现收入5.67亿元，归母净利润-2.22亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502271654129894aca7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502271654129894aca7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","06185"],"gpt_icon":0},{"id":"2514482438","title":"康希诺：2024年实现营业收入84633.81万元，同比增加137.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514482438","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514482438?lang=zh_cn&edition=full","pubTime":"2025-02-27 16:20","pubTimestamp":1740644423,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2514274410","title":"康希诺生物盘中异动 快速拉升5.09%报39.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514274410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514274410?lang=zh_cn&edition=full","pubTime":"2025-02-26 09:49","pubTimestamp":1740534565,"startTime":"0","endTime":"0","summary":"2025年02月26日早盘09时49分，康希诺生物股票出现波动，股价急速拉升5.09%。截至发稿，该股报39.250港元/股，成交量79.56万股，换手率0.60%，振幅3.61%。资金方面，该股资金流入1757.74万港元，流出981.736万港元。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中，整体涨幅为0.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022609492596307fda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022609492596307fda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","06185","688185"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1744553957630,"stockEarnings":[{"period":"1week","weight":-0.0879},{"period":"1month","weight":-0.0967},{"period":"3month","weight":0.0031},{"period":"6month","weight":0.043},{"period":"1year","weight":0.0839},{"period":"ytd","weight":-0.0945}],"compareEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":-0.0396},{"period":"3month","weight":0.022},{"period":"6month","weight":0.0064},{"period":"1year","weight":0.0672},{"period":"ytd","weight":-0.0339}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康希诺生物股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18230人(较上一季度减少3.63%)","perCapita":"6296股","listingDate":"2020-08-13","address":"天津市东丽区经济技术开发区西区南大街185号西区生物医药园四层401-420","registeredCapital":"24744万元","survey":"　　康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司的主要产品是疫苗及相关产品、药品生产工艺研究开发业务（CDMO）。公司获得了天津市制造业单项冠军企业、天津市专精特新中小企业、天津市先进级智能工厂等多个荣誉。","listedPrice":209.71},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.4","shortVersion":"4.32.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺,688185,康希诺股票,康希诺股票老虎,康希诺股票老虎国际,康希诺行情,康希诺股票行情,康希诺股价,康希诺股市,康希诺股票价格,康希诺股票交易,康希诺股票购买,康希诺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}